Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

7th Eurasian Hematology Oncology Summit
A

How I Treat Newly Diagnosed MM in 2020: Is VTD Superior to VCD? Is D-VTd Beneficial for PFS/OS in Transplant-Eligible Disease? Should We Use Thalidomide Maintenance After ASCT?

By 7th Eurasian Hematology Oncology Summit FEATURING Angelo Maiolino
By 7th Eurasian Hematology Oncology Summit FEATURING Angelo Maiolino
147 views
December 9, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip
Myeloma
18:43

2020 Updates on CAR-T in R/R MM: What Is the Incidence of AEs With b…

7th Eurasian Hematology Oncology Summit

E. Terpos

123 views
14:20

How I Treat Newly Diagnosed MM in 2020: Is VTD Superior to VCD? Is D…

7th Eurasian Hematology Oncology Summit

A. Maiolino

147 views
16:17

VRd, KRd and IRd in R/R MM: Real World vs. Clinical Trial Data

7th Eurasian Hematology Oncology Summit

A. Chari

489 views
15:49

2020 Updates on Maintenance Therapies in MM: Should We Consider Doub…

7th Eurasian Hematology Oncology Summit

M. Gavriatopoulou

85 views